ZimVie Inc. (NASDAQ:ZIMV – Get Free Report) fell 3% during mid-day trading on Monday . The company traded as low as $21.01 and last traded at $21.02. 14,346 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 344,108 shares. The stock had previously closed at $21.67.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC reiterated a “buy” rating and issued a $20.00 price target on shares of ZimVie in a report on Tuesday, June 25th.
Check Out Our Latest Report on ZIMV
ZimVie Stock Down 2.3 %
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.08 EPS for the quarter. ZimVie had a negative net margin of 56.31% and a positive return on equity of 2.01%. The business had revenue of $118.20 million during the quarter. During the same period in the previous year, the business earned $0.25 earnings per share. On average, equities research analysts forecast that ZimVie Inc. will post 0.63 earnings per share for the current year.
Hedge Funds Weigh In On ZimVie
Large investors have recently made changes to their positions in the company. Scarborough Advisors LLC purchased a new stake in ZimVie in the 4th quarter valued at about $28,000. Summit Securities Group LLC boosted its position in ZimVie by 518.6% in the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock valued at $55,000 after buying an additional 2,515 shares during the period. Heritage Wealth Advisors boosted its position in ZimVie by 172,750.0% in the 1st quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock valued at $114,000 after buying an additional 6,910 shares during the period. EMC Capital Management purchased a new stake in ZimVie in the 1st quarter valued at about $228,000. Finally, SG Americas Securities LLC boosted its position in ZimVie by 27.2% in the 4th quarter. SG Americas Securities LLC now owns 14,152 shares of the company’s stock valued at $251,000 after buying an additional 3,029 shares during the period. 95.63% of the stock is owned by hedge funds and other institutional investors.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
- Five stocks we like better than ZimVie
- Bank Stocks – Best Bank Stocks to Invest In
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- How to Invest in Biotech Stocks
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- Which Wall Street Analysts are the Most Accurate?
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.